Mutations of the CHMP2B, a gene encoding a subunit of the ESCRT-III protein, have been identified in some patients with front temporal dementia [55] and amyotrophic lateral sclerosis [56], thus, suggesting that impaired ESCRT-III function can contribute to neurodegenerative disorders. The gene discussed is CHMP2B; the disease is amyotrophic lateral sclerosis.